Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Hochfellner Daniel |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2025

Originalarbeit (Zeitschrift)

** Hochfellner, D; Poettler, T; Schoerghuber, M; Lukic, E; Yates, A; Keeling, I; Zimpfer, D; Aberer, F; Berti, F; Lucarelli, F; Valgimigli, F; Mader, J Accuracy and Safety of a Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a Cardiothoracic ICU: A Pilot Trial.
J Diabetes Sci Technol. 2025; 19322968251342598 Doi: 10.1177/19322968251342598
PubMed FullText FullText_MUG

 

2024

Kurzbericht/Letter

** Aberer, F; Haberl, HC; Elsayed, H; Pöttler, T; Hochfellner, DA; Mader, JK Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy.
Diabetes Obes Metab. 2024; 26(9):4111-4115 Doi: 10.1111/dom.15719
Web of Science PubMed FullText FullText_MUG

 

2023

Originalarbeit (Zeitschrift)

** Mader, JK; Brix, JM; Aberer, F; Vonbank, A; Resl, M; Hochfellner, DA; Ress, C; Pieber, TR; Stechemesser, L; Sourij, H [Hospital diabetes management (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 242-255. Doi: 10.1007/s00508-023-02177-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Kastner, JR; Poettler, T; Kopanz, J; Hochfellner, DA; Romey, M; Baumann, PM; Muchmore, D; Strasma, PJ; Mader, JK Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies.
Diabetes Obes Metab. 2023; 25(4):1106-1111 Doi: 10.1111/dom.14935
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Baumann, P; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, S; Heller, S; Gall, MA; De Galan, B; Pieber, T; Choudhary, P; Mader, J ASSOCIATION OF SENSOR-DETECTED HYPOGLYCAEMIC EPISODES (SDHE) WITH HYPOGLYCAEMIA FROM SMBG IN 15 CLINICAL TRIALS WITH SHORT-DURATION CGM. PRELIMINARY RESULTS FROM THE HYPO-RESOLVE DATABASE
DIABETES TECHNOL THE. Abstracts. 2023; 25(S2):A157-A157.-ATTD 2023 Conference; FEB 22-25, 2023; Berlin, GERMANY. [Poster]
Web of Science

 

** Baumann, PM; Cigler, M; Hochfellner, D; Kuznetsov, D; Rosilio, M; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Choudhary, P; Mader, JK How well does sensor-detected hypoglycaemia (SDH) from short-duration CGM reflect person-reported hypoglycaemia (PRH)?
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S753-S753.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Baumann, PM; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Pieber, TR; Choudhary, P; Mader, JK How well does sensor-detected hypoglycaemia from short-duration CGM reflect person-reported hypoglycaemia?
DIABETOLOGIA. 2023; 66(SUPPL 1):S407-S408.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Kommentar

** Hochfellner, DA; Simic, A; Taucher, MT; Sailer, LS; Kopanz, J; Pöttler, T; Mader, JK Reply to Freckmann et al. Comment on "Hochfellner et al. Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106".
Biosensors (Basel). 2023; 13(7): 710 Doi: 10.3390/bios13070710 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Originalarbeit (Zeitschrift)

** Hochfellner, DA; Simic, A; Taucher, MT; Sailer, LS; Kopanz, J; Pöttler, T; Mader, JK Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study.
Biosensors (Basel). 2022; 12(2): Doi: 10.3390/bios12020106 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Baumann, P; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, S; Heller, S; Gall, MA; De Galan, B; Pieber, T; Choudhary, P; Mader, JK SENSOR-DETECTED HYPOGLYCAEMIA IN SHORT-DURATION CGM DATA FROM MULTIPLE CLINICAL TRIALS IN DIABETES. PRELIMINARY RESULTS FROM THE HYPO-RESOLVE DATABASE.
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A31-A32.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

** Baumann, P; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK Gender differences in within-day glycaemic variations in people with T1D. Insights from long-duration CGM data from a diabetes registry
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):231-232. [Poster]
Web of Science

 

** Baumann, PM; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK Patterns of sensor-detected hypoglycaemia in long-duration CGM data from a diabetes registry
DIABETOLOGIA. 2022; 65(SUPPL 1):S323-S323. [Oral Communication]
Web of Science

 

** Cigler, M; Baumann, P; Elsayed, H; Hochfellner, D; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, J Improved HbA1c is associated with better glycemic control in continuous glucose monitoring systems, but glycemic control is not influenced by treatment type or CGM duration
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):234-234. [Poster]
Web of Science

 

** Harer, C; Hochfellner, D; Aberer, F; Mader, JK; Treiber, G Immune checkpoint inhibitor therapy-induced type 1 diabetes mellitus or precipitation of pre-symptomatic (stage 1) type 1 diabetes mellitus?
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):242-242.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Hochfellner, D; Baumann, P; Beck, P; Mader, J ALGORITHM-DRIVEN BASAL-BOLUS THERAPY IN HOSPITALIZED PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR DISCHARGE THERAPY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A28-A28.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Hochfellner, DA; Baumann, P; Reinhard, A; Pottler, T; Roubik, L; Kogler, S; Cigler, M; Treiber, G; Mader, J Switching from isCCGM without alarms to isCCGM with alarms: what is the benefit?
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):244-244.-ÖDG Jahrestagung 2022; NOV 17-19; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Hochfellner, DA; Baumann, PM; Reinhard, AK; Mader, JK Introduction of isCGM with glucose alarms to regular isCGM users under real-life conditions: What is the benefit?
DIABETOLOGIA. 2022; 65(SUPPL 1):S350-S350.-EASD 2022; SEP 19-23, 2022; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

** Kastner, J; Poettler, T; Kopanz, J; Hochfellner, D; Siegl, R; Romey, M; Muchmore, D; Strasma, P; Mader, J CURRENT INSULIN INFUSION SET CRITERIA DO NOT REPRESENT REAL-LIFE SETTING AND MAY SKEW INFUSION SET FAILURE OUTCOMES IN EXTENDED-WEAR INFUSION SET STUDIES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A212-A212.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

** Pottler, T; Kastner, J; Kopanz, J; Hochfellner, D; Romey, M; Muchmore, D; Strasma, P; Mader, J Current insulin infusion set criteria do not represent real-life setting and may skew infusion set failure outcomes in extended wear infusion set studies
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):255-255. [Oral Communication]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Aberer, F; Hochfellner, DA; Mader, JK Application of Telemedicine in Diabetes Care: The Time is Now.
Diabetes Ther. 2021; 12(3):629-639 Doi: 10.1007/s13300-020-00996-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Fischer, LT; Hochfellner, DA; Knoll, L; Pöttler, T; Mader, JK; Aberer, F Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.
Cardiovasc Diabetol. 2021; 20(1): 89-89. Doi: 10.1186/s12933-021-01283-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hochfellner, DA; Rainer, R; Ziko, H; Aberer, F; Simic, A; Lichtenegger, KM; Beck, P; Donsa, K; Pieber, TR; Fruhwald, FM; Rosenkranz, AR; Kamolz, LP; Baumann, PM; Mader, JK; Plank, J Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type 2 diabetes using decision support technology: A post hoc analysis.
Diabetes Obes Metab. 2021; 23(9):2161-2169 Doi: 10.1111/dom.14458
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Aberer, F; Hochfellner, DA; Sourij, H; Mader, JK A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital.
J Clin Med. 2021; 10(10): Doi: 10.3390/jcm10102154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Baumann, PM; Cigler, M; Ziko, H; Kuznetsov, D; Rosilio, M; Hochfellner, DA; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Choudhary, P; Mader, J Between- and within-subject variability of hypoglycaemia detected by short-duration CGM in multiple clinical trials in diabetes: variance decomposition of hypoglycaemic events in repeated CGM runs,
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):233-233. [Poster]
Web of Science

 

** Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Cigler, M; Elsayed, H; Ziko, H; Hochfellner, D; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, JK Shorter Diabetes Duration and Residual Beta Cell Function are associated with better glycemic Control as measured by continuous Glucose Monitoring in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):212-212. [Oral Communication]
Web of Science

 

** Groselj-Strele, A; Elsayed, H; Cigler, M; Ziko, H; Hochfellner, DA; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Mader, JK Influence of Seasons on glycemic Control as measured with CGM Metrics in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):219-219. [Oral Communication]
Web of Science

 

** Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209. [Poster]
Web of Science

 

** Secco, K; Ziko, H; Pottler, T; Hochfellner, D; Weitgasser, R; Schutz-Fuhrmann, I; Mader, JK Glycemic control in type 1 diabetes during COVID-19 pandemic
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):220-220. [Keynote lecture]
Web of Science

 

** Simic, A; Taucher, M; Hochfellner, D; Dietrich, M; Porttler, T; Aberer, F; Mader, J ACCURACY ASSESSMENT OF THE NEW GLUCOMEN (R) DAY CGM SYSTEM IN INDIVIDUALS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2021; 23: A117-A117. [Poster]
Web of Science

 

** Simic, A; Taucher, M; Hochfellner, D; Pottler, T; Aberer, F; Mader, J Glucomen Day (R) CGM system accuracy assessment in individuals with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-200. [Poster]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Aberer, F; Theiler-Schwetz, V; Ziko, H; Hausegger, B; Wiederstein-Grasser, I; Hochfellner, DA; Eller, P; Tomberger, G; Ellmerer, M; Mader, JK; Bubalo, V Accuracy and stability of an arterial sensor for glucose monitoring in a porcine model using glucose clamp technique.
Sci Rep. 2020; 10(1): 6604-6604. Doi: 10.1038/s41598-020-63659-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Pöttler, T; Mueller, A; Eckstein, ML; Sourij, H; Mader, JK, , Hypo-RESOLVE, Consortium People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to performing a glucose scan during hypoglycaemia: a prospective observational study.
Diabet Med. 2020; 37(12):2153-2159 Doi: 10.1111/dme.14362 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aberer, F; Hochfellner, D; Ziko, H; Sagmeister, MH; Cigler, M; Simic, A; Pottler, T; Sendlhofer, G; Beck, P; Mader, JK Efficiency and Safety of an electronic Decision Support System for Insulin Therapy in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S334-S334. [Poster]
Web of Science

 

** Cigler, M; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK; Moser, O People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to perform a glucose scan during hypoglycaemia: a prospective observational study.
DIABETOLOGIA. 2020; 63(SUPPL 1):S359-S359.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; virtuell. [Poster]
Web of Science

 

** Eckstein, M; Ziko, H; Moser, O; Elsayed, H; Cigler, M; Hochfellner, D; Pottler, T; Mueller, A; Sourij, H; Mader, J DISCREPANCY OF GLYCAEMIC RANGES IN REGARD TO CGM METRICS FOR CLINICAL CARE VERSUS GUIDANCE FOR GLYCAEMIC TARGETS WITHIN THE RECENT CONSENSUS ON TIR.
DIABETES TECHNOL THE. 2020; 22: A106-A106. [Poster]
Web of Science

 

** Fischer, LT; Aberer, F; Hochfellner, D; Knoll, L; Pottler, T; Mader, JK Prescribing Indications and metabolic Effects of PCSK9-Inhibitors in a tertiary Center - A retrospective Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S349-S349.-ÖDG ; [Poster]
Web of Science

 

** Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ; [Poster]
Web of Science

 

** Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Hochfellner, D; Rainer, R; Aberer, F; Lichtenegger, K; Beck, P; Fruhwald, F; Rosenkranz, A; Kamolz, LP; Mader, JK; Plank, J Safe Basal-Bolus-Insulin Therapy during Fasting Episodes in hospitalized People with Type 2 Diabetes through Decision Support Technology.
WIEN KLIN WOCHENSCHR. 2020; 132: S339-S340. [Oral Communication]
Web of Science

 

** Hochfellner, D; Schondorff, P; Stumpe, T; Heschel, M; Pottler, T; Elsayed, H; Simic, A; Bytyqi, K; Augustin, T; Lueger, A; Mader, J COMPARISON OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED ARTIFICIALLY CLOGGED LANTERN CATHETER VS. STANDARD INFUSION SET IN TYPE 1 DIABETES UNDER REAL-LIFE CONDITIONS.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A240-A241.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pottler, T; Treiber, G; Simic, A; Aberer, F; Mader, J Scan-Behavior in People with Type-1-Diabetes and Flash-Glucose-Monitoring in a Real-World-Setting.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):76-76.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Onlinepräsentation]
Web of Science

 

** Hochfellner, DA; Rainer, R; Aberer, F; Lichtenegger, KM; Beck, P; Fruhwald, F; Rosenkranz, AR; Kamolz, LP; Mader, JK; Plank, J Effective and safe basal-bolus insulin therapy during fasting episodes in hospitalised patients with type 2 diabetes using decision support technology.
DIABETOLOGIA. 2020; 63(SUPPL 1):S377-S378.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Hochfellner, DA; Ziko, H; Sagmeister, MH; Elsayed, H; Cigler, M; Poettler, T; Aberer, F; Sendlhofer, G; Beck, P; Mader, JK Electronic Decision Support for Insulin Therapy Is Safe and Efficient in Inpatients with Type 2 Diabetes.
DIABETES. 2020; 69(S 1):-80th Scientific Sessions American Diabetes Association (ADA); JUN 12-16,2020; Chicago, IL, USA;. Doi: 10.2337/db20-24-OR [Oral Communication]
Web of Science FullText FullText_MUG

 

** Moser, O; Ziko, H; Eckstein, M; Elsayed, H; Cigler, M; Hochfellner, D; Poettler, T; Mueller, A; Sourij, H; Mader, J TIME IN RANGE (TIR) ACHIEVEMENT IN REGARD TO CLINICAL TARGETS IN PEOPLE WITH TYPE 1 DIABETES (PWT1D): A REAL WORLD SETTING.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A231-A231.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Moser, O; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, M; Sourij, H; Mader, JK The FreeStyle Libre 1 isCGM System as the first objective Measuring Instrument for the Diagnosis of Hypoglycemia Unawareness in People with Type 1 Diabetes - A prospective Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S344. [Poster]
Web of Science

 

** Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Poettler, T; Mueller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia Have a Delayed Reaction to Perform a Glucose Scan during Hypoglycemia: A Prospective Observational Study.
DIABETES. 2020; 69: -80th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 12-16, 2020; ELECTR NETWORK. Doi: 10.2337/db20-157-OR [Onlinepräsentation]
Web of Science FullText FullText_MUG

 

** Simic, A; Ziko, H; Pottler, T; Hochfellner, D; Samonigg, J; Cigler, M; Beck, P; Aberer, F; Mader, JK A retrospective assessment of blinded continuous glucose monitor accuracy during inpatient management of adults with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S363-S363. [Poster]
Web of Science

 

Kommentar

** Eckstein, ML; Knoll, L; Pöttler, T; Hochfellner, DA; Müller, A; Sourij, H; Moser, O; Mader, JK Interpreting the recent consensus on time in range for interstitial glucose right - Or wrong?
Diabetes Res Clin Pract. 2020; 162:108106 Doi: 10.1016/j.diabres.2020.108106
Web of Science PubMed FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Moser, O; Pandis, M; Aberer, F; Kojzar, H; Hochfellner, D; Elsayed, H; Motschnig, M; Augustin, T; Kreuzer, P; Pieber, TR; Sourij, H; Mader, JK A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
Diabetes Obes Metab. 2019; 21(4):1043-1048 Doi: 10.1111/dom.13598 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Elsayed, H; Bytyqi, K; Simic, A; Cigler, M; Hochfellner, D; Ziko, H; Knoll, L; Pottler, T; Aberer, F; Mader, J Influence of C-Peptide Status on Frequency and Mean Duration of Hypoglycemia, Time in Blood Sugar Target Range and HbA1c in Type 1 Diabetics using Flash Glucose Monitoring in clinical Routine
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471. [Oral Communication]
Web of Science

 

** Hochfellner, D; Ziko, H; Ajsic, A; Pandis, M; Beck, P; Mader, JK HOW DOES INPATIENT DIABETES MANAGEMENT AFFECT DISCHARGE SUGGESTIONS?
DIABETES TECHNOL THE. 2019; 21: A67-A68. [Poster]
Web of Science FullText

 

** Hochfellner, DA; Ziko, H; Beck, P; Sendlhofer, G; Mader, J Benefits of a Diabetes-Management-System in inpatient Care.
WIEN KLIN WOCHENSCHR. 2019; 131: S441-S441. [Poster]
Web of Science

 

** Hochfellner, DA; Ziko, H; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, J Flash Glucose Monitoring in Routine Clinical Use in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470. [Poster]
Web of Science

 

** Simic, A; Elsayed, H; Ziko, H; Hochfellner, D; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK The effect of glucose scanning frequency on HbA1c in individuals with type 1 diabetes using FGM
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S482-S482. [Keynote lecture]
Web of Science

 

** Ziko, H; Hochfellner, D; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK Influence of Flash Glucose Monitoring on Glycemic Target Achievement
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S487-S487. [Poster]
Web of Science

 

2018

Abstract (Zeitschrift)

** Hochfellner, D; Holler, V; Sutter, S; Kohler, G Diabetic alert dogs: Medical and social assistance for patients with diabetes mellitus type 1
WIEN KLIN WOCHENSCHR. 2018; 130: 347-347. [Poster]
Web of Science

 

2015

Abstract (Zeitschrift)

** Hochfellner, DA; Binder, B; Ribitsch, W; Horina, JH; Rosenkranz, AR; Schilcher, G CALCIPHYLAXIS - A MULTI-INTERVENTIONAL TREATMENT REGIMEN INCLUDING VITAMIN K SUPPLEMENTATION MIGHT REDUCE MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS
NEPHROL DIAL TRANSPL. 2015; 30: -52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation; MAY 28-31, 2015; London, ENGLAND. Doi: 10.1093/ndt/gfv188.87 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

© Med Uni Graz Impressum